In contrast, for colon cancer patients’ receiving 5-fluorouracil, folinic acid, and oxaliplatin as therapy, the survival probability was higher when organic cation transporter-3 expression is high [19]. The gene discussed is SLC22A3; the disease is malignant colon neoplasm.